Increased risk of exacerbating gastrointestinal disease among elderly patients following treatment with calcium channel blockers.

Hamada, A; Ishii, J; Doi, K; Hamada, N; Miyazaki, C; Hamada, T; Ohwaki, Y; Wada, M; Nakashima, K

Hamada, A; Ishii, J; Doi, K; Hamada, N; Miyazaki, C; Hamada, T; Ohwaki, Y; Wada, M; Nakashima, K.

Affiliation

Hamada A; Health Care Pharmacy Ltd.

J Clin Pharm Ther ; 33(6): 619-24, 2008 Dec.

Article in En | MEDLINE | ID: mdl-19138239

Subject(s)

Calcium Channel Blockers/adverse effects; Gastrointestinal Diseases/etiology; Histamine H2 Antagonists/therapeutic use; Proton Pump Inhibitors/therapeutic use; Aged; Aged, 80 and over; Calcium Channel Blockers/therapeutic use; Cohort Studies; Esophageal Sphincter, Lower/drug effects; Esophageal Sphincter, Lower/metabolism; Female; Gastrointestinal Diseases/epidemiology; Gastrointestinal Diseases/prevention & control; Humans; Japan/epidemiology; Male; Middle Aged; Prevalence; Proportional Hazards Models; Retrospective Studies

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Calcium Channel Blockers / Proton Pump Inhibitors / Gastrointestinal Diseases / Histamine H2 Antagonists Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: J Clin Pharm Ther Journal subject: FARMACIA / TERAPEUTICA Year: 2008 Type: Article

Fulltext

XML

PubMed Links

Search on Google